Tn-seq screens in Candida glabrata treated with echinocandins and ibrexafungerp reveal pathways of antifungal resistance and cross-resistance
Open accessThe DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Abstract
Candida glabrata (also known as Nakaseomyces glabratus ) is the second most common cause of candidiasis, next to Candida albicans, and is rising in prevalence due to intrinsic and acquired mechanisms of antifungal resistance. This study utilizes transposon mutagenesis and deep sequencing (Tn-seq) to explore mechanisms of resistance to four different echinocandins (micafungin, anidulafungin, rezafungin, and caspofungin) and a non-echinocandin inhibitor (ibrexafungerp) of beta-1,3-glucan synthase (GS) in the BG2 strain background. Contrary to the other antifungals, caspofungin susceptibility exhibited high dependence on sphingolipid genes and low dependence on mitochondrial genes. Numerous deficiencies in mitochondrial genes increased fitness in micafungin, anidulafungin, rezafungin, and ibrexafungerp largely through effects on Pdr1, a stress-activated transcription factor known to promote fluconazole resistance. Several targets of Pdr1 ( RTA1, LAF1, LAC1, IPT1, and RSB1 ) altered resistance to one or more of the GS inhibitors when overexpressed individually. Though Gal11 and other subunits of the mediator complex were necessary for the Pdr1 effects, an inhibitor of Gal11 (iKIX1) did not synergize with micafungin due to off-target antagonistic effects. Substantial variation was observed in the genetic resistance spectra for the different GS inhibitors within the BG2 strain background and comparison to the CBS138 strain background. The intra-strain variation was linked to gene deficiencies thought to alter phospholipid and ergosterol composition or asymmetry in cellular membranes. The findings generally support and extend earlier hypotheses that a lipid code governs GS inhibition and antifungal susceptibility in C. glabrata . IMPORTANCE: Echinocandins and ibrexafungerp are important antifungals that target the same fungal enzyme. When the fungus acquires resistance to one of these antifungals, it may or may not exhibit cross-resistance to the others. This study investigates how every gene in the pathogenic yeast Candida glabrata contributes to resistance and cross-resistance to all five antifungals of this type. It offers new insights into how each antifungal interacts with the target enzyme and identifies the antifungals where cross-resistance is common or rare, providing guidance on the sequences and combinations that may be most effective in clinical settings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Strong evidence shows that mitochondrial dysfunction can increase resistance to echinocandins (Fig. 2) by activating Pdr1, which induces expression of lipid flippases (Rta1, Rsb1) that somehow lower susceptibility to most echinocandins (21).”
From Echinocandin tolerance and persistence in vitro are regulated by calcineurin signaling in Candida glabrata (2026) · cites this paper as [21]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“When these Z-scores were charted against resistance Z-scores obtained previously with 8 ng/mL micafungin (21), the correlation was poor (Fig. 2).”
From Echinocandin tolerance and persistence in vitro are regulated by calcineurin signaling in Candida glabrata (2026) · cites this paper as [21]
The cited source says what the claim attributes to it.
In the citing paper
“Additionally, the survival kinetics of several mutants that decreased (fks2∆, pdr1∆) or increased (mrp20∆) resistance to micafungin (21) were indistinguishable from those of the BG14 parent strain (Fig. S4).”
From Echinocandin tolerance and persistence in vitro are regulated by calcineurin signaling in Candida glabrata (2026) · cites this paper as [21]
The cited source says what the claim attributes to it.
In the citing paper
“Interestingly, the HOG signaling pathway is naturally polymorphic in different strains of C. glabrata, contributing to variation in the resistance to micafungin (21) and other stressors (41), as well as variation in tolerance and persistence within the species.”
From Echinocandin tolerance and persistence in vitro are regulated by calcineurin signaling in Candida glabrata (2026) · cites this paper as [21]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Curiously, the CRZ1, CNA1, and CNB1 genes did not exhibit significant Z-scores in Tn-seq experiments assessing resistance to echinocandins (21).”
From Echinocandin tolerance and persistence in vitro are regulated by calcineurin signaling in Candida glabrata (2026) · cites this paper as [21]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast gapped-read alignment with Bowtie 2
Langmead, B., & Salzberg, S. L. (2012) · Nature Methods · doi:10.1038/nmeth.1923 · Cited by 56,400 · cited 1×
“FastQ files were demultiplexed according to their index using CutAdapt and mapped to the BG2 v1 genome (73) or CBS138 v2 genome (74) with Bowtie2 (75).”
Sikorski, R. S., & Hieter, P. (1989) · Genetics · doi:10.1093/genetics/122.1.19 · Cited by 8,664
Global incidence and mortality of severe fungal disease
Denning, D. W. (2024) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(23)00692-8 · Cited by 1,640
Dujon, B., Sherman, D., Fischer, G., Durrens, P., Casaregola, S., Lafontaine, I., de Montigny, J., Marck, C., Neuvéglise, C., Talla, E., et al. (2004) · Nature · doi:10.1038/nature02579 · Cited by 1,623 · cited 1×
“Strain 2001 is from Kitada et al. (77), CBS138 is from Dujon et al. (78), BG2 is from Cormack and Falkow (79), and pdr1∆ is from Orta-Zavalza et al. (80).”
Pfaller, M. A., Diekema, D. J., Turnidge, J. D., Castanheira, M., & Jones, R. N. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy358 · Cited by 825 · cited 1×
“(also known as Nakaseomyces glabratus ) is the second most common cause of candidia sis, its prevalence has been rising rapidly, possibly due to its innate resistance to azole-class antifungals and easily acquired resistance to echinocandin-class antifungals (7–9).”
Global trends in the distribution of Candida species causing candidemia
Guinea, J. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12539 · Cited by 680
Resistance to echinocandin-class antifungal drugs.
Perlin, D. S. (2007) · Drug Resistance Updates · doi:10.1016/j.drup.2007.04.002 · Cited by 512 · cited 11×
“The FKS1 and FKS2 genes, which encode the catalytic subunits of GS, and MID2 , which encodes a positive regulator of Rho1, an essential subunit of GS (33–35), were significantly underrepresen ted ( Z −3.0) at multiple doses in the BG2u pool, as observed previously in CBS138u and 2001u (Fig.”
InfluentialIdentification of Yeast Rho1p GTPase as a Regulatory Subunit of 1,3-β-Glucan Synthase
Qadota, H., Python, C. P., Inoue, S. B., Arisawa, M., Anraku, Y., Zheng, Y., Watanabe, T., Levin, D. E., & Ohya, Y. (1996) · Science · doi:10.1126/science.272.5259.279 · Cited by 445
An expanded tool kit for the auxin‐inducible degron system in budding yeast
Morawska, M., & Ulrich, H. D. (2013) · Yeast · doi:10.1002/yea.2967 · Cited by 429 · cited 1×
“The ScURA3 transgene was removed by a similar method in which the hygromycin resistance gene was amplified from the pHYG-AID plasmid (83) with overhangs corresponding to the first and last 60 nucleotides of the ScURA3 gene.”
Pfaller, M. A., Castanheira, M., Lockhart, S. R., Ahlquist, A. M., Messer, S. A., & Jones, R. N. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.06112-11 · Cited by 377
Pomorski, T., Lombardi, R., Riezman, H., Devaux, P. F., van Meer, G., & Holthuis, J. C. M. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-08-0501 · Cited by 353 · cited 1×
“The DNF1 gene, encoding a lipid flippase (55, 56), seemed to match the patterns of some of the sphingolipid genes.”
A nuclear receptor-like pathway regulating multidrug resistance in fungi
Thakur, J. K., Arthanari, H., Yang, F., Pan, S.-J., Fan, X., Breger, J., Frueh, D. P., Gulshan, K., Li, D. K., Mylonakis, E., et al. (2008) · Nature · doi:10.1038/nature06836 · Cited by 343 · cited 1×
“Interestingly, four subunits of the mediator complex ( MED2, GAL11A, SIN4, and NUT1 ), which promote transcription of CDR1 by interacting with Pdr1 (50), were also highly indexed.”
Rho1p, a Yeast Protein at the Interface Between Cell Polarization and Morphogenesis
Drgonová, J., Drgon, T., Tanaka, K., Kollár, R., Chen, G.-C., Ford, R. A., Chan, C. S. M., Takai, Y., & Cabib, E. (1996) · Science · doi:10.1126/science.272.5259.277 · Cited by 336 · cited 1×
“The FKS1 and FKS2 genes, which encode the catalytic subunits of GS, and MID2 , which encodes a positive regulator of Rho1, an essential subunit of GS (33–35), were significantly underrepresen ted ( Z −3.0) at multiple doses in the BG2u pool, as observed previously in CBS138u and 2001u (Fig.”
InfluentialMolecular mechanisms governing antifungal drug resistance
Lee, Y., Robbins, N., & Cowen, L. E. (2023) · npj Antimicrobials and Resistance · doi:10.1038/s44259-023-00007-2 · Cited by 304 · cited 1×
“LOF mutations that alter resistance to antifungals can shed light on the biological processes that fungal cells naturally utilize to sense stresses, mitigate damage, and alter influx, efflux, access, or metabolism of the antifungals themselves (54).”
Ferrari, S., Ischer, F., Calabrese, D., Posteraro, B., Sanguinetti, M., Fadda, G., Rohde, B., Bauser, C., Bader, O., & Sanglard, D. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000268 · Cited by 295 · cited 2×
“A variety of GOF mutants of PDR1 have been isolated from azole-treated patients that appear to bypass the requirement for upstream signals that emanate from dysfunctional mitochondria (29).”
Worsening Spread of Candida auris in the United States, 2019 to 2021
Lyman, M., Forsberg, K., Sexton, D. J., Chow, N. A., Lockhart, S. R., Jackson, B. R., & Chiller, T. (2023) · Annals of Internal Medicine · doi:10.7326/m22-3469 · Cited by 287
Garcia-Effron, G., Park, S., & Perlin, D. S. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01162-08 · Cited by 256 · cited 1×
“Most amino acid substitutions confer cross-resistance to all three of the original echinocandins: caspofun gin, micafungin, and anidulafungin (12, 18).”
Sanglard, D., Ischer, F., & Bille, J. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.4.1174-1183.2001 · Cited by 247
Tsai, H.-F., Krol, A. A., Sarti, K. E., & Bennett, J. E. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1384-1392.2006 · Cited by 237 · cited 1×
“Dozens of genes have been identified as direct targets of the Pdr1 transcription factor (42–45).”
Vermitsky, J., Earhart, K. D., Smith, W. L., Homayouni, R., Edlind, T. D., & Rogers, P. D. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05235.x · Cited by 233 · cited 1×
“Even the ABC transporters CDR1 and its paralog PDH1 , which are both induced by Pdr1 activation and strongly involved in azole resistance (43), exhibited elevated fitness in micafungin when disrupted with transpo sons.”
Pham, C. D., Iqbal, N., Bolden, C. B., Kuykendall, R. J., Harrison, L. H., Farley, M. M., Schaffner, W., Beldavs, Z. G., Chiller, T. M., Park, B. J., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03255-14 · Cited by 231 · cited 1×
“Most amino acid substitutions confer cross-resistance to all three of the original echinocandins: caspofun gin, micafungin, and anidulafungin (12, 18).”
Structural and mechanistic insights into fungal β-1,3-glucan synthase FKS1
Hu, X., Yang, P., Chai, C., Liu, J., Sun, H., Wu, Y., Zhang, M., Zhang, M., Liu, X., & Yu, H. (2023) · Nature · doi:10.1038/s41586-023-05856-5 · Cited by 213 · cited 4×
“Our genetic findings add support to hypothesis 1 of Hu et al. (17), which postulates that GS inhibition involves specific drug-lipid interactions in addition to specific drug-target and lipid-target interactions that both may be impacted by GOF mutations (20).”
InfluentialGlobal Analysis of the Evolution and Mechanism of Echinocandin Resistance in Candida glabrata
Singh-Babak, S. D., Babak, T., Diezmann, S., Hill, J. A., Xie, J. L., Chen, Y.-L., Poutanen, S. M., Rennie, R. P., Heitman, J., & Cowen, L. E. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002718 · Cited by 205
Activity of 1,3-β-D-Glucan Synthase Requires the GTP-binding Protein Rho1
Mazur, P., & Baginsky, W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.24.14604 · Cited by 196 · cited 1×
“The FKS1 and FKS2 genes, which encode the catalytic subunits of GS, and MID2 , which encodes a positive regulator of Rho1, an essential subunit of GS (33–35), were significantly underrepresen ted ( Z −3.0) at multiple doses in the BG2u pool, as observed previously in CBS138u and 2001u (Fig.”
InfluentialSchwarzmüller, T., Ma, B., Hiller, E., Istel, F., Tscherner, M., Brunke, S., Ames, L., Firon, A., Green, B., Cabral, V., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004211 · Cited by 191 · cited 1×
“Apart from the GOF mutations in GS itself, many patient isolates and laboratory isolates harbor loss-of-function (LOF) mutations in other genes that confer significant resistance to inhibitors (24, 25).”
Candida auris Pan-Drug-Resistant to Four Classes of Antifungal Agents
Jacobs, S. E., Jacobs, J. L., Dennis, E. K., Taimur, S., Rana, M., Patel, D., Gitman, M., Patel, G., Schaefer, S., Iyer, K., et al. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00053-22 · Cited by 190
Cormack, B. P., & Falkow, S. (1999) · Genetics · doi:10.1093/genetics/151.3.979 · Cited by 180
Kaur, R., Castaño, I., & Cormack, B. P. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1600-1613.2004 · Cited by 167 · cited 1×
“Several studies have hypothesized that C. glabrata and related pathogens may transiently generate mitochondrial deficiencies through genetic or epigenetic mechanisms that later can be reversed (62, 67).”
Burden of Candidemia in the United States, 2017
Tsay, S. V., Mu, Y., Williams, S., Epson, E., Nadle, J., Bamberg, W. M., Barter, D. M., Johnston, H. L., Farley, M. M., Harb, S., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa193 · Cited by 163
Kitada, K., Yamaguchi, E., & Arisawa, M. (1995) · Gene · doi:10.1016/0378-1119(95)00552-h · Cited by 153 · cited 1×
“Strain 2001 is from Kitada et al. (77), CBS138 is from Dujon et al. (78), BG2 is from Cormack and Falkow (79), and pdr1∆ is from Orta-Zavalza et al. (80).”
Hoenigl, M., Salmanton-García, J., Egger, M., Gangneux, J.-P., Bicanic, T., Arikan-Akdagli, S., Alastruey-Izquierdo, A., Klimko, N., Barac, A., Özenci, V., et al. (2023) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(22)00872-6 · Cited by 152
Mechanisms of Azole Resistance in Petite Mutants of Candida glabrata
Brun, S., Bergès, T., Poupard, P., Vauzelle-Moreau, C., Renier, G., Chabasse, D., & Bouchara, J.-P. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1788-1796.2004 · Cited by 151 · cited 9×
“Such mechanisms could result in the activation of Pdr1 and increased expression of CDR1 , RTA1 , and other targets that positively impact both fitness and antifungal resistance in various host environments.”
InfluentialCloning, disruption and sequence of the gene encoding yeast C-5 sterol desaturase
Arthington, B. A., Bennett, L. G., Skatrud, P. L., Guynn, C. J., Barbuch, R. J., UIbright, C. E., & Bard, M. (1991) · Gene · doi:10.1016/0378-1119(91)90535-j · Cited by 149 · cited 1×
“ERG3 and ERG4 disruptions that alter the biosynthesis of ergosterol (58, 59) increased fitness only in anidulafungin.”
Katiyar, S. K., Alastruey-Izquierdo, A., Healey, K. R., Johnson, M. E., Perlin, D. S., & Edlind, T. D. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00813-12 · Cited by 148 · cited 1×
“Clinical resistance to echinocandins typically arises through gain-of-function (GOF) mutations in the target genes ( FKS1 and FKS2 ), which redundantly encode catalytic subunits of beta-1,3-glucan synthase (GS), an enzyme responsible for synthesizing a critical component of the cell wall (15).”
Inhibiting fungal multidrug resistance by disrupting an activator–Mediator interaction
Nishikawa, J. L., Boeszoermenyi, A., Vale-Silva, L. A., Torelli, R., Posteraro, B., Sohn, Y.-J., Ji, F., Gelev, V., Sanglard, D., Sanguinetti, M., et al. (2016) · Nature · doi:10.1038/nature16963 · Cited by 146 · cited 2×
“Here, we tested iKIX1, an inhibitor of Gal11A and Gal11B subunits of the mediator complex (51), for its ability to increase micafungin potency.”
Ferrari, S., Sanguinetti, M., De Bernardis, F., Torelli, R., Posteraro, B., Vandeputte, P., & Sanglard, D. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01271-10 · Cited by 144 · cited 1×
“Mitochondrial deficiencies potently activate the Pdr1 transcription factor and induce the expression of several target genes such as CDR1 (39–41).”
Salmanton-García, J., Cornely, O. A., Stemler, J., Barać, A., Steinmann, J., Siváková, A., Akalin, E. H., Arikan-Akdagli, S., Loughlin, L., Toscano, C., et al. (2024) · Journal of Infection · doi:10.1016/j.jinf.2024.106229 · Cited by 127
Athenstaedt, K., & Daum, G. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.24.7611-7616.1997 · Cited by 126 · cited 1×
“An opposite pattern was exhibited by the SLC1 gene, whose product synthesizes the lipid phosphati dic acid (57).”
Ksiezopolska, E., Schikora-Tamarit, M. À., Beyer, R., Nunez-Rodriguez, J. C., Schüller, C., & Gabaldón, T. (2021) · Current Biology · doi:10.1016/j.cub.2021.09.084 · Cited by 107 · cited 2×
“LOF mutations in ERG3 were previously associated with anidulafungin resistance in long-term evolution experiments (10).”
Genomewide Expression Profile Analysis of the Candida glabrata Pdr1 Regulon
Caudle, K. E., Barker, K. S., Wiederhold, N. P., Xu, L., Homayouni, R., & Rogers, P. D. (2011) · Eukaryotic Cell · doi:10.1128/ec.00073-10 · Cited by 94
Yeast Whi2 and Psr1‐phosphatase form a complex and regulate STRE‐mediated gene expression
Kaida, D., Yashiroda, H., Toh‐e, A., & Kikuchi, Y. (2002) · Genes to Cells · doi:10.1046/j.1365-2443.2002.00538.x · Cited by 93 · cited 1×
“Another was WHI2 , which encodes a regulatory subunit of the protein phosphatases encoded by PSR1 and PSR2 (36), all of which exhibited high Z -scores in micafungin (Fig.”
Johnson, M. E., Katiyar, S. K., & Edlind, T. D. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01811-10 · Cited by 91 · cited 1×
“However, several different GOF substitutions in Fks1 were found to differentiate caspofungin from the other two echinocandins (19), suggesting the binding sites of these antifungals only partially overlap.”
Jiménez-Ortigosa, C., Perez, W. B., Angulo, D., Borroto-Esoda, K., & Perlin, D. S. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00833-17 · Cited by 89 · cited 1×
“Some of the GOF mutants that were strongly resistant to all echinocandins remained susceptible to ibrexafungerp and vice versa (23).”
Schroeder, M., Weber, T., Denker, T., Winterland, S., Wichmann, D., Rohde, H., Ozga, A.-K., Fischer, M., & Kluge, S. (2020) · Annals of Intensive Care · doi:10.1186/s13613-020-00755-8 · Cited by 89
In-vivo selection of an azole-resistant petite mutant of Candida glabrata
BOUCHARA, J.-P., LE BOUDOUIL, S., FILMON, R., ZOUHAIR, R., HALLET, J.-N., CHABASSE, D., RENIER, G., & DEFONTAINE, A. (2000) · Journal of Medical Microbiology · doi:10.1099/0022-1317-49-11-977 · Cited by 88 · cited 1×
“Mitochondrial gene deficiencies (petite mutants) have been recovered from untreated patients (62) and patients undergoing treatment with fluconazole (63, 64) or caspofungin (65).”
Expression Plasmids for Use in Candida glabrata
Zordan, R. E., Ren, Y., Pan, S.-J., Rotondo, G., Peñas, A. D. L., Iluore, J., & Cormack, B. P. (2013) · G3 Genes|Genomes|Genetics · doi:10.1534/g3.113.006908 · Cited by 82 · cited 2×
“The products and the expression plasmid pCN-PDC1 (46) were digested, ligated together, transformed into Escherichia coli , and authenticated by Sanger sequencing (Genewiz).”
CRS–MIS in Candida glabrata: sphingolipids modulate echinocandin–Fks interaction
Healey, K. R., Katiyar, S. K., Raj, S., & Edlind, T. D. (2012) · Molecular Microbiology · doi:10.1111/j.1365-2958.2012.08194.x · Cited by 79 · cited 3×
“Previous studies in strain 2001u showed that knockout mutants of two sphingolipid genes ( FEN1 and CKA2 ) increased resistance to caspofungin and decreased resistance to micafungin (32).”
The complete mitochondrial genome sequence of the pathogenic yeast Candida (Torulopsis) glabrata
Koszul, R., Malpertuy, A., Frangeul, L., Bouchier, C., Wincker, P., Thierry, A., Duthoy, S., Ferris, S., Hennequin, C., & Dujon, B. (2003) · FEBS Letters · doi:10.1016/s0014-5793(02)03749-3 · Cited by 78 · cited 1×
“Off-target antagonism between caspofungin and rotenone, an inhibitor of mitochondrial respiratory complex I that is absent in C. glabrata (68), has been observed previously (26).”
Zweytick, D., Hrastnik, C., Kohlwein, S. D., & Daum, G. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01290-4 · Cited by 76 · cited 1×
“ERG3 and ERG4 disruptions that alter the biosynthesis of ergosterol (58, 59) increased fitness only in anidulafungin.”
Structure of a fungal 1,3-β-glucan synthase
Zhao, C.-R., You, Z.-L., Chen, D.-D., Hang, J., Wang, Z.-B., Ji, M., Wang, L.-X., Zhao, P., Qiao, J., Yun, C.-H., et al. (2023) · Science Advances · doi:10.1126/sciadv.adh7820 · Cited by 75
Miyazaki, T., Inamine, T., Yamauchi, S., Nagayoshi, Y., Saijo, T., Izumikawa, K., Seki, M., Kakeya, H., Yamamoto, Y., Yanagihara, K., et al. (2010) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2010.00611.x · Cited by 70
Lee, A. (2021) · Drugs · doi:10.1007/s40265-021-01571-5 · Cited by 66 · cited 2×
“Ibrexafungerp is an orally available inhibitor of fungal GS that is chemically unrelated to micafungin and the other echinocandins (22).”
Vale-Silva, L., Ischer, F., Leibundgut-Landmann, S., & Sanglard, D. (2013) · Infection and Immunity · doi:10.1128/iai.00074-13 · Cited by 65 · cited 1×
“PDR1-GOF mutants may have smaller fitness defects in host niches and even promote fitness in the bloodstream (30), unlike mitochondrial LOF mutants.”
Syed, Y. Y. (2023) · Drugs · doi:10.1007/s40265-023-01891-8 · Cited by 65
Zhai, B., Liao, C., Jaggavarapu, S., Tang, Y., Rolling, T., Ning, Y., Sun, T., Bergin, S. A., Gjonbalaj, M., Miranda, E., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-03183-4 · Cited by 62 · cited 1×
“Heteroresistance, where only a small subpopulation of fungal cells reversibly acquires echinocandin resistance, was recently linked to micafungin failure in C. parapsilosis (69).”
Orta‐Zavalza, E., Guerrero‐Serrano, G., Gutiérrez‐Escobedo, G., Cañas‐Villamar, I., Juárez‐Cepeda, J., Castaño, I., & De Las Peñas, A. (2013) · Molecular Microbiology · doi:10.1111/mmi.12247 · Cited by 61 · cited 1×
“Strain 2001 is from Kitada et al. (77), CBS138 is from Dujon et al. (78), BG2 is from Cormack and Falkow (79), and pdr1∆ is from Orta-Zavalza et al. (80).”
Beardsley, J., Kim, H. Y., Dao, A., Kidd, S. E., Alastruey‐Izquierdo, A., Sorrell, T. C., Tacconelli, E., Chakrabarti, A., Harrison, T. S., Bongomin, F., et al. (2024) · Medical Mycology · doi:10.1093/mmy/myae041 · Cited by 61 · cited 1×
“(also known as Nakaseomyces glabratus ) is the second most common cause of candidia sis, its prevalence has been rising rapidly, possibly due to its innate resistance to azole-class antifungals and easily acquired resistance to echinocandin-class antifungals (7–9).”
Arastehfar, A., Daneshnia, F., Cabrera, N., Penalva-Lopez, S., Sarathy, J., Zimmerman, M., Shor, E., & Perlin, D. S. (2023) · Nature Communications · doi:10.1038/s41467-023-36882-6 · Cited by 58 · cited 3×
“Persistence mechanisms that regulate the percentage of tolerant cells within susceptible populations represent another underexplored means by which fungal cells survive our antifungal assaults (66, 70).”
Gregori, C., Schüller, C., Roetzer, A., Schwarzmüller, T., Ammerer, G., & Kuchler, K. (2007) · Eukaryotic Cell · doi:10.1128/ec.00106-07 · Cited by 57 · cited 1×
“The third gene that was non-functional in CBS138u but functional and impactful in BG2u was SSK2 , which encodes a MAPKKK of the high osmolarity (HOG) signaling pathway (37).”
Healey, K. R., Nagasaki, Y., Zimmerman, M., Kordalewska, M., Park, S., Zhao, Y., & Perlin, D. S. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01412-17 · Cited by 57 · cited 2×
“An inhibitor of chitin synthesis (nikkomycin Z) increased micafungin activity in vitro (48) and increased caspofungin activity in vivo (49).”
Gale, A. N., Sakhawala, R. M., Levitan, A., Sharan, R., Berman, J., Timp, W., & Cunningham, K. W. (2020) · G3 Genes|Genomes|Genetics · doi:10.1534/g3.120.401595 · Cited by 56 · cited 1×
“This strain was transformed with pCU-MET3-Hermes, and then transposition was induced in 40 replicate cultures (72).”
Self-citationCandida glabrata candidemia: An emerging threat in critically ill patients
Gupta, A., Varma, A., & Gupta, A. (2015) · Indian Journal of Critical Care Medicine · doi:10.4103/0972-5229.152757 · Cited by 50
Caspofungin Uptake Is Mediated by a High-Affinity Transporter in Candida albicans
Paderu, P., Park, S., & Perlin, D. S. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.10.3845-3849.2004 · Cited by 49 · cited 1×
“…Fks1 from S. cerevisiae has revealed its active site near the cytoplasmic face of the plasma membrane (17, 60), which suggests that the GS inhibitors may need to flip from the outer to the inner leaflet of the plasma membrane or be transported through the membrane (61) to access its binding sites.”
Xu, Z., Green, B., Benoit, N., Schatz, M., Wheelan, S., & Cormack, B. (2020) · Molecular Microbiology · doi:10.1111/mmi.14488 · Cited by 48 · cited 1×
“FastQ files were demultiplexed according to their index using CutAdapt and mapped to the BG2 v1 genome (73) or CBS138 v2 genome (74) with Bowtie2 (75).”
Paul, S., Bair, T. B., & Moye-Rowley, W. S. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03921-14 · Cited by 45 · cited 1×
“Dozens of genes have been identified as direct targets of the Pdr1 transcription factor (42–45).”
Simonicova, L., & Moye-Rowley, W. S. (2020) · PLOS Genetics · doi:10.1371/journal.pgen.1009005 · Cited by 45 · cited 1×
“First, the ura3∆ pdr1∆::HYG strain (CGM1094) was converted to ura3∆ PDR1-GOF (TJN88) by transformation with a PCR product obtained from plasmid pLS9 (71) that carries PDR1-R376W-Y584C-P822L , a derivative of PDR1 bearing three gain-of-function mutations within the core regulatory domain.”
Edlind, T. D., Henry, K. W., Vermitsky, J., Edlind, M. P., Raj, S., & Katiyar, S. K. (2005) · Current Genetics · doi:10.1007/s00294-005-0008-3 · Cited by 38 · cited 1×
“Knockout mutants were made using the PRODIGE technique (81), which involves amplifying the Saccharomyces cerevisiae URA3 or HIS3 genes from the pRS406 or pRS403 plasmids (82) with 60-nucleotide primer homology arms that correspond to the flanking regions of the target gene.”
Siscar-Lewin, S., Gabaldón, T., Aldejohann, A. M., Kurzai, O., Hube, B., & Brunke, S. (2021) · mBio · doi:10.1128/mbio.01128-21 · Cited by 36 · cited 2×
“Mitochondrial gene deficiencies (petite mutants) have been recovered from untreated patients (62) and patients undergoing treatment with fluconazole (63, 64) or caspofungin (65).”
Cell wall protein variation, break‐induced replication, and subtelomere dynamics in Candida glabrata
Xu, Z., Green, B., Benoit, N., Sobel, J. D., Schatz, M. C., Wheelan, S., & Cormack, B. P. (2021) · Molecular Microbiology · doi:10.1111/mmi.14707 · Cited by 29
Garcia-Rubio, R., Jimenez-Ortigosa, C., DeGregorio, L., Quinteros, C., Shor, E., & Perlin, D. S. (2021) · mBio · doi:10.1128/mbio.01959-21 · Cited by 29 · cited 2×
“Off-target antagonism between caspofungin and rotenone, an inhibitor of mitochondrial respiratory complex I that is absent in C. glabrata (68), has been observed previously (26).”
Gale, A. N., Pavesic, M. W., Nickels, T. J., Xu, Z., Cormack, B. P., & Cunningham, K. W. (2023) · mSphere · doi:10.1128/msphere.00254-23 · Cited by 27
Self-citationArastehfar, A., Daneshnia, F., Hovhannisyan, H., Fuentes, D., Cabrera, N., Quinteros, C., Ilkit, M., Ünal, N., Hilmioğlu-Polat, S., Jabeen, K., et al. (2023) · mBio · doi:10.1128/mbio.01180-23 · Cited by 27
Conformational changes of a phosphatidylcholine flippase in lipid membranes
Xu, J., He, Y., Wu, X., & Li, L. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110518 · Cited by 26 · cited 1×
“The DNF1 gene, encoding a lipid flippase (55, 56), seemed to match the patterns of some of the sphingolipid genes.”
Healey, K. R., Challa, K. K., Edlind, T. D., & Katiyar, S. K. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04667-14 · Cited by 23 · cited 1×
“Interestingly, LOF mutations in several genes required for sphingolipid biosynthe sis have been shown to increase resistance to caspofungin, while at the same time decreasing resistance to micafungin in C. glabrata , C. albicans , and the mold Aspergillus nidulans (31, 32).”
Calcineurin-dependent contributions to fitness in the opportunistic pathogen Candida glabrata
Pavesic, M. W., Gale, A. N., Nickels, T. J., Harrington, A. A., Bussey, M., & Cunningham, K. W. (2024) · mSphere · doi:10.1128/msphere.00554-23 · Cited by 22 · cited 2×
“The alg6∆ and alg8∆ mutants of BG2u have been shown to cause chronic stresses that weakly activate calcineurin signaling and increase the expression of target genes such as RCN2 (38).”
Self-citationArastehfar, A., Daneshnia, F., Floyd, D. J., Jeffries, N. E., Salehi, M., Perlin, D. S., Ilkit, M., Lass-Flöerl, C., & Mansour, M. K. (2024) · mBio · doi:10.1128/mbio.00072-24 · Cited by 19 · cited 1×
“Persistence mechanisms that regulate the percentage of tolerant cells within susceptible populations represent another underexplored means by which fungal cells survive our antifungal assaults (66, 70).”
Hassoun, Y., Aptekmann, A. A., Keniya, M. V., Gomez, R. Y., Alayo, N., Novi, G., Quinteros, C., Kaya, F., Zimmerman, M. D., Cáceres, D. H., et al. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012521 · Cited by 16 · cited 4×
“LOF mutations in three sphingolipid genes ( FEN1 , SUR2, and SUR4 ), which have been isolated from patients undergoing caspofungin treatment (25), were also found to have similar behaviors.”
InfluentialMutational landscape and molecular bases of echinocandin resistance in Saccharomyces cerevisiae
Durand, R., Torbey, A. G., Giguère, M., Pageau, A., Dubé, A. K., Lagüe, P., & Landry, C. R. (2026) · Genetics · doi:10.1093/genetics/iyag055 · Cited by 16 · cited 2×
“Our genetic findings add support to hypothesis 1 of Hu et al. (17), which postulates that GS inhibition involves specific drug-lipid interactions in addition to specific drug-target and lipid-target interactions that both may be impacted by GOF mutations (20).”
Steier, Z., Vermitsky, J.-P., Toner, G., Gygax, S. E., Edlind, T., & Katiyar, S. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02394-12 · Cited by 14 · cited 9×
“For qRT-PCR data, four replicate samples were compared using an unpaired two-tailed t -test for different strains, and a paired two-tailed t -test for drug-treated samples at time zero compared to 1.5 h of treatment.”
InfluentialWang, Q., Tu, J., Yang, W., Liang, T., Liu, N., & Sheng, C. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00488 · Cited by 12 · cited 2×
“Second-generation inhibitors of Gal11A/B have now been developed (52, 53), which potentially may lack the off-target effect and potentiate micafungin in addition to fluconazole, even when clinical resistance has occurred through gain-of-function mutations in Pdr1.”
Mutational landscape and molecular bases of echinocandin resistance in Saccharomyces cerevisiaePreprint
Durand, R., Torbey, A. G., Giguere, M., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.21.604487 · Cited by 12
Nickels, T. J., Gale, A. N., Harrington, A. A., Timp, W., & Cunningham, K. W. (2024) · G3 Genes Genomes Genetics · doi:10.1093/g3journal/jkae173 · Cited by 12
Self-citationKołaczkowska, A., Dyląg, M., & Kołaczkowski, M. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.01.047 · Cited by 9 · cited 1×
“Interestingly, overexpression of a related lipid flippase encoded by RSB1 , which is not a target of Pdr1 (47), resulted in strong resistance to anidulafungin, moderate resistance to rezafungin and micafungin, and no resistance to ibrexafungerp (Fig.”
Identification of novel inhibitors against Med15a KIX domain of Candida glabrata
Waseem, M., Das, S., Mondal, D., Jain, M., Thakur, J. K., & Subbarao, N. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.126720 · Cited by 6 · cited 2×
“Second-generation inhibitors of Gal11A/B have now been developed (52, 53), which potentially may lack the off-target effect and potentiate micafungin in addition to fluconazole, even when clinical resistance has occurred through gain-of-function mutations in Pdr1.”
Cited by
Pathogenicity and virulence of Candida auris
Phan-Canh, T., Seiser, S., Chauhan, M., Kuchler, K., Chauhan, N., & Elbe‐Bürger, A. (2026) · Virulence · doi:10.1080/21505594.2026.2707827 · Cited by 7
Harrington, A. A., Nickels, T. J., & Cunningham, K. W. (2026) · mBio · doi:10.1128/mbio.02546-25 · Cited by 4
Self-citationZaeske, A. M., Harrington, A. A., Nickels, T. J., Gale, A. N., Timp, W., Alayo, N., Hassoun, Y., Perlin, D. S., Shor, E., & Cunningham, K. W. (2026) · Microbiology Spectrum · doi:10.1128/spectrum.00848-26 · Cited by 2
Self-citationNatural Product-Inspired Antifungal Drugs Introduced for Human Use from 1872 to August 2026
Butler, M. S., & Capon, R. J. (2026) · Antibiotics · doi:10.3390/antibiotics15090938 · Cited by 1
“Ibrexafungerp is distinguished from echinocandins by oral bioavailability and by retained activity against many, though not all, echinocandin-resistant isolates [351,352].”
Wu, J., Su, D., Niu, Z., Liu, S., Li, C., Ye, J., & Zhou, X. (2026) · BMC Microbiology · doi:10.1186/s12866-026-04985-x
“Similarly, deletion of RtaA enhances susceptibility to the antifungal sterol analog 7-aminocholesterol in S. cerevisiae and Candida glabrata [27].”
Metadata
- Authors
- Nickels, T. J., & Cunningham, K. W.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Cunningham, Kyle W.
- Venue
- mSphere
- Publisher
- American Society for Microbiology
- Published
- 2025-07-29
- Volume
- 10
- Issue
- 7
- Pages
- e0027025-e0027025
- ISSN
- 2379-5042 (ISSN-L)
- PMC
- PMC12306164
- OpenAlex
- W4412070012
- Semantic Scholar
- dd9db9838229ed68436c2caaaea4e8d436607202
- Cited by
- 8
- References
- 83
- Citations by year
- 2026: 7 · 2025: 1
- FWCI
- 6.11
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (vor)
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- mSphere (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institute of Allergy and Infectious Diseases (R01-AI153414)
- National Institute of General Medical Sciences (T32-GM007231)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
- Keywords
- Candida glabrata, echinocandins, ibrexafungerp, antifungal resistance, cross-resistance, beta-1,3-glucan synthase, PDR1, sphingolipid biosynthesis, mitochondrial genes, Mediator complex, Gal11, caspofungin, micafungin, anidulafungin, rezafungin
- MeSH terms
- Micafungin, Antifungal Agents, DNA Transposable Elements, Fungal Proteins, Glucosyltransferases, Glycosides, Microbial Sensitivity Tests, Triterpenes, Mutagenesis, Insertional, Drug Resistance, Fungal, Candida glabrata, Echinocandins, High-Throughput Nucleotide Sequencing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.